Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VIA Equity Fund III K/S invests in GleSYS AB and Portlane AB
Mandate

VIA Equity Fund III K/S invests in GleSYS AB and Portlane AB

May 08, 2018 IT, Telecommunications and Outsourcing

Vinge has advised VIA Equity Fund III K/S, together with the current owners, founders and CEO Glenn Johansson, in connection with the investment in GleSYS AB and Portlane AB through a new, jointly owned, holding structure.

GleSYS and Portlane offer services within colocation, dedicated servers, network and connections, system management and virtual private servers. The companies’ joint turnover is approximately SEK 100 million with good profitability.

Vinge’s team consisted primarily of Johan Winnerblad, Alex Miler, Andrea Ahlgren, Marith Welin-Berger and Viktor Wahlqvist.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026